We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Octopus Group

HEMOCUE AB

HemoCue AB develops, produces, and markets medical diagnostic products for point of care testing (POC) markets. Its p... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Hematological Neoplasm Cytogenetics Profiled With Optical Genome Mapping

By LabMedica International staff writers
Posted on 25 Oct 2022
Print article
Image: The Bionano Genomics Saphyr platform offers sample preparation, DNA imaging and genomic data analysis technologies combined into one streamlined workflow that enables one to identify structural variants and create de novo genome assemblies (Photo courtesy of Bionano Genomics)
Image: The Bionano Genomics Saphyr platform offers sample preparation, DNA imaging and genomic data analysis technologies combined into one streamlined workflow that enables one to identify structural variants and create de novo genome assemblies (Photo courtesy of Bionano Genomics)

The current standard-of-care cytogenetic techniques for the analysis of hematological malignancies include karyotyping, fluorescence in situ hybridization, and chromosomal microarray analysis (CMA), which are labor intensive and time and cost prohibitive, and they often do not reveal the genetic complexity of the tumor, demonstrating the need for alternative technology for better characterization of these tumors.

Optical genome mapping (OGM) has emerged as a next-generation cytogenomic technology that can detect all classes of SVs at a higher resolution than the standard-of-care (SOC) techniques. Recently, the technology has gained enormous traction and has been evaluated in several settings, including prenatal settings, postnatal settings, hematological neoplasms, and solid tumors, demonstrating 100% clinical concordance with traditional cytogenetic analysis.

Medical Scientists at the Medical College of Georgia (Augusta, GA, USA) performed a retrospective validation study included 92 analyses (including replicates), representing 69 unique and well-characterized samples that were received in their clinical laboratory for cytogenetic analysis with karyotyping and/or FISH testing. These were composed of 59 hematological neoplasms that included 18 adult acute myeloid leukemia (AML), 15 chronic lymphocytic leukemia (CLL), 12 myelodysplastic syndrome (MDS), six plasma cell myeloma, three lymphoma, three myeloproliferative disorders/myeloproliferative neoplasms, and two chronic myeloid leukemia. In addition, 10 morphologically normal and cytogenetically negative samples were also analyzed to evaluate true-negative/false-positive rates and calculate performance metrics.

Ultra-high-molecular-weight DNA was isolated, labeled, and processed for analysis on the Bionano Genomics Saphyr platform (Bionano Genomics Inc., San Diego, CA, USA). A frozen bone marrow aspirate aliquot (650 μL) was thawed, and cells were counted using HemoCue (HemoCue Holding AB, Ängelholm, Sweden). The DNA backbone was stained blue using DNA stain and quantified using Qubit high-sensitivity double-stranded DNA assay kits. Labeled DNA was loaded onto flow cells of Saphyr chips for optical imaging. The fluorescently labeled DNA molecules were imaged on the Saphyr instrument after the labeled DNA molecules were electrophoretically linearized in the nanochannel arrays.

The team reported that all 69 samples passed the quality control metrics, and the 59 hematological neoplasm samples achieved an average N50 (>150 kb) of 303 kb (±35), map rate of 87.5% (±7.5%), label density of 15.8/100 kb (±1.0), and average coverage of 391× (±89). In total, 86,306 SVs were identified in the 59 samples, with an average of approximately 1,462 SVs per sample. OGM was concordant in identifying 162 of 164 variants, which were reported with current SOC methods. OGM detected 59 of 60 aneuploidies, whereas one mosaic loss of chromosome Y (in a complex case of CLL) was not detected with OGM.

Of the 45 cases classified as simple, 35 had at least one clinically reported genetic aberration, whereas 10 were negative with both karyotyping and/or FISH testing. In the 35 cases with reported aberrations, OGM detected all of the previously reported variants and corrected the previously incorrect interpretations due to low resolution of karyotyping in two cases. The translocation, interstitial deletion, and duplication were detected consistently from 25% to 5% allele fraction.

The authors concluded that their study showed a 98.7% sensitivity and a 100% specificity for detecting SVs previously reported with a combination of SOC methods. The increased clinical utility of OGM in hematological malignancies has been established by multiple reports where 100% concordance was reported with multiple SOC methods. The study was published on October 17, 2022 in the Journal of Molecular Diagnostics.

Related Links:
Medical College of Georgia
Bionano Genomics
HemoCue Holding AB

Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Radiotherapy Toxicity Measurement Assay
Radiotherapy Toxicity Measurement Assay
New
Silver Supplier
Real-Time PCR Thermal Cycler
Eonis Q96
New
Alpha-1 Antitrypsin Deficiency Test
A1AT Genotyping Test

Print article

Channels

Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more

Immunology

view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more

Microbiology

view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more

Pathology

view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more

Technology

view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more

Industry

view channel
Image: The global antimicrobial resistance diagnostics market size is expected to reach USD 5.7 billion by 2028 (Photo courtesy of Pexels)

Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections

Antimicrobial drugs are intended to counteract the harmful effects of microbes and promote a healthy life. However, their excessive use can result in the development of resistance, commonly referred to... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.